Author

Chee Kin Lam

Observed names: C. K. Lam, C. Kin Lam, C. Lam

Institution: National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention

Observed institutions: Centers for Disease Control and Prevention, New York City Department of Health and Mental Hygiene, San Francisco Department of Public Health, National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention

ORCID: 0000-0002-4821-4898

Observed ORCID: 0000-0002-4821-4898

OpenAlex ID: A5006713228

Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study

2018 · Chee Kin Lam, Kara McGinnis Pilote, et al. · Journal of Medical Internet Research · 59

In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial

2022 · Joseph Burzynski, Joan M. Mangan, et al. · JAMA Network Open · 57

Improved treatment completion with shorter treatment regimens for latent tuberculous infection

2018 · M. M. Macaraig, M. Jalees, et al. · The International Journal of Tuberculosis and Lung Disease · 41

Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017–2018)

2020 · Garrett R. Beeler Asay, Chee Kin Lam, et al. · American Journal of Public Health · 32

Recommendations for Use of Video Directly Observed Therapy During Tuberculosis Treatment — United States, 2023

2023 · Joan M. Mangan, Rachel S. Woodruff, et al. · MMWR Morbidity and Mortality Weekly Report · 30

Cost savings associated with video directly observed therapy for treatment of tuberculosis

2019 · C. K. Lam, K. Fluegge, et al. · The International Journal of Tuberculosis and Lung Disease · 17

Outbreak of Multidrug-Resistant Tuberculosis — Kansas, 2021–2022

2023 · Elizabeth Groenweghe, Lauren Swensson, et al. · MMWR Morbidity and Mortality Weekly Report · 13

Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months — California, January–March, 2023

2024 · Scott A. Nabity, Rocio Agraz-Lara, et al. · MMWR Morbidity and Mortality Weekly Report · 5

Large Tuberculosis Outbreaks — United States, 2017–2023

2026 · Kala M. Raz, Maryam B. Haddad, et al. · MMWR Morbidity and Mortality Weekly Report · 2

Adverse events among persons with TB using in-person vs. electronic directly observed therapy

2023 · M. M. Salerno, J. Burzynski, et al. · The International Journal of Tuberculosis and Lung Disease · 1

Challenges associated with electronic and in-person directly observed therapy during a randomized trial

2023 · J. M. Mangan, J. Burzynski, et al. · The International Journal of Tuberculosis and Lung Disease · 1

Works count: 11

Citation count: 258

H-index: 7

I10-index: 7